Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
1.070
-0.050 (-4.46%)
Mar 26, 2026, 4:00 PM EDT - Market closed
Elutia Employees
As of December 31, 2025, Elutia had 26 total employees, including 25 full-time and 1 part-time employees. The number of employees decreased by 25 or -49.02% compared to the previous year.
Employees
26
Change (1Y)
-25
Growth (1Y)
-49.02%
Revenue / Employee
$472,808
Profits / Employee
$2,053,077
Market Cap
45.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 26 | -25 | -49.02% | 25 | 1 |
| Dec 31, 2024 | 51 | -3 | -5.56% | 51 | 0 |
| Dec 31, 2023 | 54 | -110 | -67.07% | 54 | 0 |
| Sep 30, 2023 | 53 | -113 | -68.07% | 53 | 0 |
| Jun 30, 2023 | 151 | -11 | -6.79% | 151 | 0 |
| Mar 31, 2023 | 144 | -13 | -8.28% | 144 | 0 |
| Dec 31, 2022 | 164 | -12 | -6.82% | 164 | 0 |
| Sep 30, 2022 | 166 | -10 | -5.68% | 166 | 0 |
| Jun 30, 2022 | 162 | -13 | -7.43% | 162 | 0 |
| Mar 31, 2022 | 157 | -14 | -8.19% | 157 | 0 |
| Dec 31, 2021 | 176 | 13 | 7.98% | 176 | 0 |
| Sep 30, 2021 | 176 | 20 | 12.82% | 176 | 0 |
| Jun 30, 2021 | 175 | 25 | 16.67% | 175 | 0 |
| Mar 31, 2021 | 171 | 21 | 14.00% | 171 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Accuray | 990 |
| Outset Medical | 310 |
| Pulmonx | 296 |
| Cytosorbents | 149 |
| Spectral AI | 78 |
| electroCore | 73 |
| IceCure Medical | 66 |
| Sensus Healthcare | 60 |
ELUT News
- 9 days ago - Elutia to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19 - GlobeNewsWire
- 13 days ago - Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 15 days ago - Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process - GlobeNewsWire
- 22 days ago - Elutia Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 24 days ago - Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market - GlobeNewsWire
- 4 weeks ago - Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026 - GlobeNewsWire
- 5 weeks ago - Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™ - GlobeNewsWire
- 2 months ago - Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones - GlobeNewsWire